ClinicalTrials.gg
CompletedNCT07150156Updated Sep 21, 2026

A Non-Inferiority Trial of an Electronic vs Face-to-face Brief Intervention After Alcohol Screening in Two Countries

An interventional study of brief intervention following alcohol screening and brief intervention following alcohol screening in Alcohol Use Disorder, sponsored by HBSA. Completed at 2 sites in 2 countries. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by HBSA · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Feb 2025, registered Aug 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
1,439
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to compare two different strategies to deliver brief interventions to people whose scores on the Alcohol Use Disorders Identification Test (AUDIT) suggest that their level of alcohol use may be unhealthy. Brief interventions typically seek to increase the awareness of people whose alcohol use may be unhealthy of the extent and potential adverse consequences of their substance use, and then to provide guidance and motivate them to reduce their consumption. Due to limitations in the use of traditional brief interventions delivered face-to-face by health care providers, applications have been developed to support the electronic delivery of brief interventions. The main question posed in this study is: Is an electronic brief intervention (eBI) delivered via an app on a handheld device at least as effective in reducing alcohol consumption as a traditional in-person brief intervention delivered by a facilitator, who is a trained health educator? We expect that eBI will not be significantly less effective than face-to-face brief intervention.

To test the efficacy of eBI compared to traditional in-person brief intervention, researchers will compare changes in average 30-day quantity and frequency of drinking alcohol, AUDIT scores, and in several additional measures of outcomes related to risky or hazardous alcohol use between participants who received an eBI and those who received a face-to-face brief intervention. In this non-inferiority trial, the intervention (i.e., electronic brief intervention via an app) will be considered effective if it yields reductions in participants' risky or hazardous alcohol use that are no less than those produced by the comparison condition (i.e., a traditional brief intervention through an in-person interaction).

Participants will:

  • be invited to complete an alcohol screening using the AUDIT
  • be invited to be in a study of alcohol use patterns over time if they have an AUDIT score of 8 or higher
  • take a brief survey with demographic and additional recent alcohol use questions
  • receive either an eBI or an in-person brief intervention
  • complete two additional surveys at 3- and 6-month intervals after the first survey to collect information on alcohol use over time
Read the detailed description

Background and Study Purpose

As is well-documented by the World Health Organization (WHO), alcohol abuse remains a major health hazard worldwide, responsible for 5.3 percent of all deaths annually. It also contributes to over 200 conditions related to disease and injury, which include an array of behavioral and mental health disorders. There is now a substantial body of literature suggesting the effectiveness of Screening and Brief Intervention (SBI) as a strategy to identify people at high risk for alcohol use disorder, and to invite them, within the context of a short motivational interview, to reflect on their drinking patterns and develop a realistic and achievable plan to reduce their consumption. The screening component of SBI typically relies on the Alcohol Use Disorders Identification Test (AUDIT), which comprises two parts. The first is a 3-item assessment (the AUDIT-C); individuals who score 8 or higher are then invited to: (1) respond to 7 additional questions about their alcohol consumption (the AUDIT-7) and (2) participate in a brief intervention that is typically conducted by their primary health care provider or a staff member.

There are a variety of reasons, however, why brief interventions may fail to fulfill expectations of their positive effects. Eligible participants may be reluctant to engage fully in brief interventions because of the stigma attached to doing so; and primary health care providers may lack the time, attention, and confidence in their ability to conduct the brief intervention, or delegate responsibility for its administration to staff members who are insufficiently trained to deliver the intervention as intended, which includes establishing a sufficient rapport with the participant.

Consideration has thus been given to strategies to automate the delivery of brief interventions so that they can be self-administered electronically. Prototypes of this delivery mechanism are under development, and are sufficiently far advanced that they warrant investigations of their effectiveness. The key research question to be addressed by this study is:

  • Are brief interventions, as electronically self-administered via an app on handheld devices, at least as effective in reducing the 30-day quantity and frequency of alcohol consumption as brief interventions administered in person by health care providers?

Note that the study's purpose is not to determine whether the administration of brief interventions via a handheld device is superior to that of an in-person administration, but to investigate whether the two modes of delivery are at least of equal effectiveness.

Study Setting

This study will be conducted in communities in two low- and middle-income countries: Zacatecas, Mexico and Alexandra Township, South Africa. In each site approximately seven to nine hospitals and health care clinics will participate in the study.

Institutional Recruitment Procedures

A country-specific study contractor will recruit the hospitals and clinics where the SBI will be delivered. All participating institutions will express their willingness to permit the contractor's trained facilitators (health educators) to approach patients in waiting areas and administer the AUDIT screening tool to them via an electronic device. For those patients who score 8 or higher on the AUDIT-C, the institutions will agree to:

  • support the administration of the AUDIT-7;
  • agree to and support the assignment of all participating clinics on alternating weeks to either the traditional in-person brief intervention or the electronic brief intervention. Thus all patients qualifying for the study in any given week will be assigned to one group, and all those in the subsequent week will be assigned to the other group.

Study Participant Requirements and Procedures

All patients who are at least 18 years old and score 8 or above on the AUDIT will be eligible and recruited for the study as long as they have not been screened in the past six months. They will be informed of their eligibility via the consent language presented in the app after the screening and before the study survey (those who do not qualify for the study do not see the consent language or the survey but go directly from the screening to their brief intervention). Specifically, the consent form on the device will inform them that:

  • they are eligible to participate in a study on alcohol use patterns over time;
  • they will be invited to answer a few more questions about their alcohol use;
  • they will be asked to complete similar surveys in three months and again at six months, with various options, i.e., at the time of a follow-up clinic visit (for those with chronic health conditions), at a meeting with a clinic staff person at a convenient time and location, or via a phone interview in South Africa and via a link to the survey sent to them so they can complete it on their phone or other device at home or a phone interview in Mexico;
  • they will receive an incentive at the time of each survey with each successive survey incentive of increased value compared to the previous one (small cash payments in Mexico; a mobile airtime credit at baseline and grocery vouchers at the two follow-up surveys in South Africa); and
  • they will be asked to provide personal contact information to be used to recontact them at each of the two follow-up intervals.

Study Sample

All screened patients who are are aged 18 or older, who score 8 or higher on the AUDIT, and who have not been screened in the past 6 months will be eligible to participate in the study. Initial targets were to enroll 460 participants (230 in each brief intervention condition or study arm) in each country. At this point, Mexico has enrolled 563 participants (289 traditional BI; 274 electronic BI). Baseline data collection is still ongoing in South Africa.

Analysis Plan

In this non-inferiority trial, the null hypothesis is that the intervention (i.e., a BI delivered electronically via an app) is inferior to the comparison (i.e., an in-person brief intervention, or business as usual). This would be reflected in a statistically significant greater reduction in drinking alcohol post-intervention among those receiving an in-person BI compared to those receiving an electronic BI.

02

Conditions studied

  • Alcohol Use Disorder

Browse trials for

Keywords

  • alcohol use disorder
  • screening
  • brief intervention
  • electronic
03

In context

Alcoholism

1,674 studies on the registry are indexed under Alcoholism; 331 are open to participants now.

This study's enrollment of 1,439 is above the median of 88 across 1,428 interventional studies indexed under Alcoholism.

Browse Alcoholism studies →

Lead sponsor

HBSA is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 and above
  • AUDIT screening score of 8 or more

Exclusion criteria

Exclusion Criteria:

  • Having been screened for alcohol use within the past 6 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,439 participants (actual)

Study arms

  • Experimental
    electronic brief intervention

    Participants receive an electronic brief intervention via an app accessed on a handheld device

    Behavioral: brief intervention following alcohol screening

  • Active comparator
    in-person brief intervention

    Participants receive a face-to-face brief intervention via a personal discussion with a trained facilitator

    Behavioral: brief intervention following alcohol screening

Interventions

  • Behavioralbrief intervention following alcohol screening

    Provision of a brief intervention via an electronic app

  • Behavioralbrief intervention following alcohol screening

    Provision of a brief intervention via a face-to-face interaction with a trained facilitator

06

What researchers measure

Primary outcomes

  1. Average daily quantity X frequency within last 30 days

    In the past 30 days, on how many days did you have a whole drink, more than a sip or taste, of any alcoholic beverage? In the past 30 days, on the days when you drank alcohol, about how many whole drinks did you typically have?

    Time frame: 3 months and 6 months

Secondary outcomes

  1. Maximum quantity x frequency within last 30 days

    You said you usually had \[Number from Alc 2\] whole drinks when you drank alcohol. Thinking about the past 30 days, what was the greatest number of drinks with alcohol you had on any one day? In the past 30 days, on how many days did you have \[Number from Alc 3\] alcoholic drinks?

    Time frame: 3 months and 6 months

  2. 30-day frequency of 6+ drinks

    On how many days in the past 30 days did you have 6 or more alcoholic drinks on one occasion?

    Time frame: 3 months and 6 months

  3. Past 3 months total 10-item AUDIT score

    AUDIT-C + AUDIT 7 scores

    Time frame: 3 months and 6 months

07

Study locations

2 sites
  • IMSS Bienestar
    Zacatecas City, Zacatecas, Mexico
  • Friends for Life
    Johannesburg, Gauteng, South Africa
08

References and documents

Individual participant data

Plan to share: Yes — All individual participant data held by this study's investigators will be made available to other researchers following the conclusion of this study. Note that all data will be fully deidentified.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: All data will be made available within six months following the publication of a manuscript detailing the study's main findings. These data will be available indefinitely.

Access criteria: All data will be made available to interested researchers upon written request to the GSDG Data Library. The GSDG Data Library is an independent, external warehouse designed to help advance knowledge, science, and the field of public health by making all data sourced in the pursuit of the Global Smart Drinking Goals initiative available for scientific use. HBSA, the external evaluator of the GSDG Initiative, oversees the collection, coordination, measurement, and evaluation of all data collected as well as its analysis and assessment. Scientific researchers can apply to access GSDG Data Library data to replicate evaluation results, conduct their own research, and plan programs to reduce harmful alcohol consumption

Data sharing details ↗ · gsdgdatalibrary.org

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07150156
Lead sponsor
HBSA
Collaborators
AB InBev Foundation
Responsible party
Sponsor
First posted
Sep 2, 2025
Start date
Feb 17, 2025
Primary completion
Dec 4, 2025
Completion
Dec 4, 2025
Last update
Sep 21, 2026

Study contacts

Ted R Miller, Ph.D.
principal investigator · Pacific Institute for Research and Evaluation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion